Is BioNexus Gene Lab Corp. (BGLC) a Buy, Sell, or Hold?
NASDAQ : BGLC
BioNexus Gene Lab Corp. — Competitors
$1.54 USD
-$0.02 (-1.28%)
- Volume
- 2.55K
- Average Volume
- 99.31K
- Market Capitalization
- $3.1M
- P/E Ratio
- -1.04
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $8.98
- Year Low
- $1.07
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $6.52
BGLC vs. The Competition
| Properties | BGLC | ADVB | AEON | APM |
|---|---|---|---|---|
| Market Cap | $3.1M | $18.16M | $3.08M | $5.71M |
| Shares Outstanding | $2.01M | $1.08M | $11.83M | $634.68K |
| P/E Ratio | -1.04 | -78.78 | -0.05 | -4.54 |
| EPS | -1.2 | -0.53 | -4.97 | -1.85 |
| Day Low | 1.53 | 12.73 | 0.25 | 8.0611 |
| Day High | 1.59 | 20.87 | 0.2699 | 9.3409 |
| Year Low | 1.07 | 3.61 | 0.25 | 0.6 |
| Year High | 8.98 | 20.87 | 1.45 | 44.7 |
| Average Price 50 | 2.05458 | 5.14994 | 0.6499 | 8.6386 |
| Average Price 200 | 3.08974 | 6.21499 | 0.92314 | 10.12308 |
| Volume | 2548 | 11.82M | 252.78K | 33583 |
| Average Volume | - | - | - | - |